Skip to main content
OpenTrials
Completed

NCT Number: NCT00319813

General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment

A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COPD patients over 35 years of age
  • More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these

Exclusion criteria

  • Asthma

Treatment and study plan

Education

Behavioral

Primary outcomes

  1. To optimise the diagnosis and treatment of COPD via a quality assurance project

    Time frame: Up to 1.2 years

  2. Increase the knowledge and use of diagnostic tools and treatment amongst PCPs

    Time frame: Up to 1.2 years

  3. To focus on implementation of national guidelines for diagnosis and treatment of COPD

    Time frame: Up to 1.2 years

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

General Practice Quality Assurance Project. COPD Diagnosis and Treatment

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
Apr 27, 2006
Registry last updated
Dec 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.